Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sentinel Lymph Node | 1 | 2025 | 12 | 0.880 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2025 | 39 | 0.870 |
Why?
|
| Lymph Node Excision | 1 | 2025 | 45 | 0.870 |
Why?
|
| Mastectomy, Segmental | 1 | 2025 | 48 | 0.840 |
Why?
|
| Postoperative Complications | 4 | 2025 | 1322 | 0.700 |
Why?
|
| Ursidae | 2 | 2020 | 12 | 0.690 |
Why?
|
| Critical Care | 2 | 2016 | 402 | 0.670 |
Why?
|
| Breast Neoplasms | 3 | 2025 | 1222 | 0.650 |
Why?
|
| Cholecystitis, Acute | 2 | 2016 | 30 | 0.590 |
Why?
|
| Cholecystostomy | 2 | 2016 | 22 | 0.520 |
Why?
|
| Blood Coagulation | 1 | 2017 | 41 | 0.510 |
Why?
|
| Intraabdominal Infections | 1 | 2013 | 2 | 0.390 |
Why?
|
| Intensive Care Units | 1 | 2013 | 420 | 0.300 |
Why?
|
| Hibernation | 2 | 2020 | 10 | 0.300 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2023 | 570 | 0.250 |
Why?
|
| Lymphedema | 1 | 2025 | 7 | 0.220 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2023 | 27 | 0.200 |
Why?
|
| Precancerous Conditions | 1 | 2023 | 74 | 0.190 |
Why?
|
| Aged, 80 and over | 3 | 2025 | 5612 | 0.180 |
Why?
|
| MutL Proteins | 2 | 2018 | 10 | 0.180 |
Why?
|
| MutL Protein Homolog 1 | 2 | 2018 | 27 | 0.180 |
Why?
|
| Genome | 1 | 2023 | 285 | 0.170 |
Why?
|
| Seasons | 2 | 2020 | 139 | 0.160 |
Why?
|
| Hemostasis | 1 | 2020 | 19 | 0.160 |
Why?
|
| DNA Mismatch Repair | 2 | 2018 | 35 | 0.160 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 141 | 0.150 |
Why?
|
| Female | 9 | 2025 | 34016 | 0.150 |
Why?
|
| Retrospective Studies | 4 | 2025 | 6862 | 0.150 |
Why?
|
| Spores, Fungal | 1 | 2018 | 22 | 0.140 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 150 | 0.140 |
Why?
|
| Mastectomy | 1 | 2019 | 56 | 0.140 |
Why?
|
| Adult | 5 | 2025 | 17356 | 0.140 |
Why?
|
| Selection, Genetic | 1 | 2018 | 90 | 0.140 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 112 | 0.130 |
Why?
|
| Biological Specimen Banks | 1 | 2017 | 23 | 0.130 |
Why?
|
| Systems Biology | 1 | 2017 | 36 | 0.130 |
Why?
|
| Intestinal Diseases | 1 | 2018 | 37 | 0.130 |
Why?
|
| Intestinal Obstruction | 1 | 2018 | 51 | 0.130 |
Why?
|
| Aged | 4 | 2025 | 14958 | 0.130 |
Why?
|
| Tissue Donors | 1 | 2017 | 146 | 0.130 |
Why?
|
| Abdominal Pain | 1 | 2018 | 102 | 0.130 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2018 | 449 | 0.130 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2018 | 88 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2021 | 490 | 0.120 |
Why?
|
| Equipment Failure | 1 | 2016 | 63 | 0.120 |
Why?
|
| Middle Aged | 4 | 2025 | 18267 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 427 | 0.120 |
Why?
|
| Humans | 12 | 2025 | 65124 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2019 | 882 | 0.110 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2014 | 49 | 0.100 |
Why?
|
| Transcriptome | 1 | 2017 | 399 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2020 | 710 | 0.100 |
Why?
|
| Patient Safety | 1 | 2016 | 259 | 0.100 |
Why?
|
| Critical Illness | 1 | 2016 | 329 | 0.100 |
Why?
|
| Male | 6 | 2021 | 31042 | 0.090 |
Why?
|
| Cross Infection | 1 | 2013 | 164 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 731 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 2 | 2014 | 801 | 0.080 |
Why?
|
| Risk Factors | 2 | 2019 | 5429 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 272 | 0.080 |
Why?
|
| Decision Making | 1 | 2013 | 418 | 0.070 |
Why?
|
| Neoplasms | 1 | 2019 | 1367 | 0.070 |
Why?
|
| Mutation Rate | 2 | 2018 | 24 | 0.070 |
Why?
|
| Referral and Consultation | 2 | 2019 | 440 | 0.060 |
Why?
|
| Nipples | 1 | 2023 | 14 | 0.050 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2023 | 22 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2023 | 90 | 0.050 |
Why?
|
| Telomere | 1 | 2023 | 58 | 0.050 |
Why?
|
| Animals | 2 | 2020 | 21324 | 0.050 |
Why?
|
| Phylogeny | 1 | 2023 | 388 | 0.040 |
Why?
|
| Breast | 1 | 2023 | 191 | 0.040 |
Why?
|
| Appendectomy | 1 | 2021 | 57 | 0.040 |
Why?
|
| Antithrombin III | 1 | 2020 | 15 | 0.040 |
Why?
|
| Appendicitis | 1 | 2021 | 84 | 0.040 |
Why?
|
| Genomics | 1 | 2023 | 384 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 374 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 306 | 0.040 |
Why?
|
| Cues | 1 | 2019 | 79 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 222 | 0.040 |
Why?
|
| Capsule Endoscopy | 1 | 2018 | 40 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2018 | 74 | 0.030 |
Why?
|
| Length of Stay | 1 | 2021 | 827 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2020 | 430 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 111 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2018 | 82 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2017 | 99 | 0.030 |
Why?
|
| Genetic Background | 1 | 2017 | 7 | 0.030 |
Why?
|
| Emotions | 1 | 2019 | 233 | 0.030 |
Why?
|
| Alleles | 1 | 2018 | 453 | 0.030 |
Why?
|
| Homozygote | 1 | 2017 | 122 | 0.030 |
Why?
|
| Genetic Fitness | 1 | 2017 | 35 | 0.030 |
Why?
|
| DNA Repair | 1 | 2018 | 262 | 0.030 |
Why?
|
| Genotype | 1 | 2018 | 673 | 0.030 |
Why?
|
| Anemia | 1 | 2018 | 132 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 657 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 1566 | 0.030 |
Why?
|
| Computational Biology | 1 | 2017 | 367 | 0.030 |
Why?
|
| Cholecystectomy | 1 | 2014 | 34 | 0.030 |
Why?
|
| Communication | 1 | 2019 | 597 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2019 | 464 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 349 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 1785 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2483 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 1232 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1149 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 2703 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 2658 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 1656 | 0.020 |
Why?
|
| Child | 1 | 2019 | 4612 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1048 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 3310 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2014 | 5788 | 0.010 |
Why?
|